Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genocea Biosciences Inc (NASDAQ:GNCA)

5.12
Delayed Data
As of Sep 30
 +0.06 / +1.19%
Today’s Change
2.56
Today|||52-Week Range
8.20
-2.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues2.0M0.000.000.00
 
 
Depreciation And Amortization300.0K318.0K469.0K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income---318.0K-469.0K-1.1M
 
 
 
 
General Expenses14.6M20.3M33.0M41.0M
 
 
 
 
 
Research And Development10.9M15.7M23.7M28.0M
 
 
 
 
 
Total Operating Expenses14.9M20.7M33.5M42.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-20.7M-33.5M-42.0M
 
 
 
 
 
Extraordinary Credit93.0K0.00--0.00
 
 
Extraordinary Charge0.00-422.0K-1.2M0.00
 
 
 
Interest Expense On Debt507.0K459.0K970.0K1.1M
 
 
 
 
 
Other Expenses0.00731.0K308.0K670.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.4M-20.8M-35.3M-42.5M
 
 
 
 
 
Net Income-15.1M-22.4M-35.5M-42.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS295.0K17.2M15.6M24.5M
 
 
 
 
 
Shares To Calculate EPS Diluted295.0K17.2M15.6M24.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$51.35-$75.46-$2.27-$1.74
 
 
 
 
 
EPS Diluted-$51.35-$1.21-$2.27-$1.74